Case number 2017-1017
ICOS Corporation v. Actelion Pharmaceuticals, Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ICOS CORPORATION v. ACTELION PHARMACEUTICALS, LTD. [OPINION] [nonprecedential] (0) |
| May 25, 2018 | 56 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [524626] [17-1017, 17-1018] [JAB] [Entered: 05/25/2018 09:15 AM] (0) |
| Apr 18, 2018 | 55 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Nonprecedential Opinion). (For the Court: Moore, Circuit Judge; Linn, Circuit Judge and Chen, Circuit Judge). [514737] [17-1017, 17-1018] [JAB] [Entered: 04/18/2018 10:08 AM] (0) |
| Mar 7, 2018 | 54 | Letter from Appellant ICOS Corporation regarding March 6, 2018, oral argument. Service: 03/07/2018 by email. [503245] [Mark Feldstein] [Entered: 03/07/2018 02:03 PM] (0) |
| Mar 6, 2018 | 53 | Submitted after ORAL ARGUMENT by Mark J. Feldstein for ICOS Corporation and Mark Edward Waddell for Actelion Pharmaceuticals, Ltd.. Panel: Judge: Moore , Judge: Linn , Judge: Chen. [502801] [JCP] [Entered: 03/06/2018 10:49 AM] (0) |
| Feb 15, 2018 | 52 | Response to oral argument order from the Appellant ICOS Corporation. designating Mark J. Feldstein as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [497994] [Mark Feldstein] [Entered: 02/15/2018 11:00 AM] (0) |
| Feb 13, 2018 | 51 | Response to oral argument order from the Appellee Actelion Pharmaceuticals, Ltd.. designating Mark E. Waddell as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [497398] [Mark Waddell] [Entered: 02/13/2018 02:46 PM] (0) |
| Jan 22, 2018 | 50 | NOTICE OF CALENDARING. Panel: 1803F. Case scheduled Mar 06, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 203. Response to oral argument order due: 02/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [491373] [JAB] [Entered: 01/22/2018 12:13 PM] (0) |
| Jan 9, 2018 | 49 | Notice from Appellant ICOS Corporation regarding conflicts with oral argument (March 8, 2018 and April 2-9, 2018). Service: 01/09/2018 by email. [488270] [Mark Feldstein] [Entered: 01/09/2018 11:36 AM] (0) |
| Nov 17, 2017 | 48 | Notice from Appellant ICOS Corporation regarding conflicts with oral argument (February 7-9, 2018). Service: 11/17/2017 by email. [476581] [Mark Feldstein] [Entered: 11/17/2017 01:37 PM] (0) |
| Sep 12, 2017 | 47 | 6 paper copies of the Joint Appendix (Vols. I- IV) [46] received from Appellant ICOS Corporation. [460298] [CW] [Entered: 09/12/2017 09:43 AM] (0) |
| Sep 1, 2017 | 46 | APPENDIX FILED for ICOS Corporation [44]. Number of Pages: 2557. Service: 09/01/2017 by email. The paper copies of the brief should be received by the court on or before 09/13/2017. [459040] [FMS] [Entered: 09/06/2017 03:32 PM] (2557) |
| Sep 1, 2017 | 45 | Statement of Compliance with Fed. Cir. R. 33 for Appellant ICOS Corporation. Service: 09/01/2017 by email. [458409] [J. McCorquindale] [Entered: 09/01/2017 04:50 PM] (2) |
| Sep 1, 2017 | 44 | TENDERED from Appellant ICOS Corporation. Title: JOINT APPENDIX. Service: 09/01/2017 by email. [458407] [J. McCorquindale] [Entered: 09/01/2017 04:48 PM] (2557) |
| Sep 1, 2017 | 43 | Letter from Appellee Actelion Pharmaceuticals, Ltd. Notice of substitution of parties in related cases. Service: 09/01/2017 by email. [458342] [Mark Waddell] [Entered: 09/01/2017 02:42 PM] (4) |
| Aug 30, 2017 | 42 | 6 paper copies of the Reply Brief [41] received from Appellant ICOS Corporation. [457646] [CW] [Entered: 08/30/2017 10:25 AM] (0) |
| Aug 25, 2017 | 41 | REPLY BRIEF FILED for Appellant ICOS Corporation [40]. Number of Pages: 30. Service: 08/25/2017 by email. The paper copies of the brief should be received by the court on or before 09/05/2017. Appendix is due 09/01/2017. [457078] [FMS] [Entered: 08/28/2017 01:53 PM] (39) |
| Aug 25, 2017 | 40 | TENDERED from Appellant ICOS Corporation. Title: REPLY BRIEF. Service: 08/25/2017 by email. [456894] [Mark Feldstein] [Entered: 08/25/2017 05:23 PM] (39) |
| Aug 17, 2017 | 39 | Entry of appearance for J. Derek McCorquindale as of counsel for Appellant ICOS Corporation. Service: 08/17/2017 by email. [454894] [J. McCorquindale] [Entered: 08/17/2017 03:59 PM] (2) |
| Jul 6, 2017 | 38 | ORDER granting motion to extend time to file reply brief [36] filed by Appellant ICOS Corporation. No further extensions should be anticipated. ICOS Corporation's reply brief is due 08/25/2017. Service: 07/06/2017 by clerk. [444402] [NL] [Entered: 07/06/2017 10:18 AM] (2) |
| Jul 5, 2017 | 37 | RESPONSE of Appellee Actelion Pharmaceuticals, Ltd. to the motion to extend time to file reply brief [36] filed by Appellant ICOS Corporation in 17-1017. Service: 07/05/2017 by email. [444042] [Mark Waddell] [Entered: 07/05/2017 09:27 AM] (4) |
| Jul 3, 2017 | 36 | MOTION of Appellant ICOS Corporation to extend the time to 08/25/2017 at 11:59 pm to Appellee has not responded as to whether it will oppose. to file the reply brief. Any response is due within 10 days of service [Consent: not addressed]. Service: 07/03/2017 by email. [443846] [Mark Feldstein] [Entered: 07/03/2017 12:20 PM] (13) |
| Jun 30, 2017 | 35 | 6 paper copies of the Correctede Opening Response Brief [34] received from Appellee Actelion Pharmaceuticals, Ltd. [443369] [CW] [Entered: 06/30/2017 10:16 AM] (0) |
| Jun 28, 2017 | 34 | CORRECTED BRIEF FILED for Appellee Actelion Pharmaceuticals, Ltd. [33]. Number of Pages: 66. Service: 06/28/2017 by email. The paper copies of the brief should be received by the court on or before 07/07/2017. [443044] [FMS] [Entered: 06/29/2017 10:31 AM] (80) |
| Jun 28, 2017 | 33 | TENDERED from Appellee Actelion Pharmaceuticals, Ltd.. Title: CORRECTED RESPONSE BRIEF. Service: 06/28/2017 by email. [442915] [Mark Waddell] [Entered: 06/28/2017 03:49 PM] (80) |
| Jun 28, 2017 | 32 | NOTICE OF REJECTION: The Response brief of Appellee Actelion Pharmaceuticals, Ltd. [31], is not in compliance with the rules of this court and is therefore rejected for filing. Appellee Actelion Pharmaceuticals, Ltd. brief due 07/12/2017. Appellant ICOS Corporation reply brief is due 07/12/2017. Service as of this date by Clerk of Court. [442643] [FMS] [Entered: 06/28/2017 08:47 AM] (2) |
| Jun 26, 2017 | 31 | TENDERED from Appellee Actelion Pharmaceuticals, Ltd.. Title: RESPONSE BRIEF. Service: 06/26/2017 by email. [442238] This brief has been rejected. See Doc No. [32] [Mark Waddell] [Entered: 06/26/2017 09:30 PM] (0) |
| Jun 14, 2017 | 30 | Entry of appearance for Alexandra Cavazos as of counsel for Appellee Actelion Pharmaceuticals, Ltd.. Service: 06/14/2017 by email. [439155] [Alexandra Cavazos] [Entered: 06/14/2017 11:51 AM] (2) |
| Apr 17, 2017 | 29 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [424670] [JCA] [Entered: 04/17/2017 12:34 PM] (0) |
| Mar 16, 2017 | 28 | 6 paper copies of the Opening Brief [26] received from Appellant ICOS Corporation. [416259] [KW] [Entered: 03/16/2017 02:29 PM] (0) |
| Mar 15, 2017 | 27 | Appellee Actelion Pharmaceuticals, Ltd. brief is due 06/26/2017. [415815] [FMS] [Entered: 03/15/2017 04:12 PM] (0) |
| Mar 14, 2017 | 25 | TENDERED from Appellant ICOS Corporation. Title: OPENING BRIEF. Service: 03/14/2017 by email. [415362] [Mark Feldstein] [Entered: 03/14/2017 02:38 PM] (175) |
| Mar 14, 2017 | 24 | Amended Certificate of Interest for the Appellant ICOS Corporation. Service: 03/14/2017 by email. [415360] [Mark Feldstein] [Entered: 03/14/2017 02:36 PM] (3) |
| Mar 14, 2017 | 26 | BRIEF FILED for Appellant ICOS Corporation [25]. Number of Pages: 65. Service: 03/14/2017 by email. The paper copies of the brief should be received by the court on or before 03/22/2017. Appellee Actelion Pharmaceuticals, Ltd. brief is due 04/24/2017. [415686] [FMS] [Entered: 03/15/2017 12:46 PM] (175) |
| Dec 12, 2016 | 23 | ORDER filed. The motion [22] is granted to the extent that ICOS Corporation's opening brief is due no later than March 14, 2017 and Actelion Pharmaceuticals Ltd's response brief is due no later than June 26, 2017. Service: 12/12/2016 by clerk. [390165] [LMS] [Entered: 12/12/2016 03:31 PM] (2) |
| Dec 9, 2016 | 22 | MOTION of Appellant ICOS Corporation and Appellee Actelion Pharmaceuticals, Ltd. to extend the time to 03/14/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service, to extend the time to 06/26/2017 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/09/2016 by email. [389717] [Mark Feldstein] [Entered: 12/09/2016 10:39 AM] (14) |
| Nov 14, 2016 | 21 | Certified list from the United States Patent and Trademark Office. Service: 11/14/2016 by email. Appellant/Petitioner's brief is due 01/13/2017. [384301] [FMS] [Entered: 11/17/2016 04:15 PM] (94) |
| Oct 26, 2016 | 20 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [9], ERROR: Attorney Dan L. Wood submitted an entry of appearance without updating his CM/ECF account. CORRECTION: Update your law firm and address through CM/ECF ASAP. [377817] [FMS] [Entered: 10/26/2016 03:22 PM] (0) |
| Oct 20, 2016 | 19 | Official caption revised to correct typographical errors. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [376156] [FMS] [Entered: 10/20/2016 11:00 AM] (0) |
| Oct 19, 2016 | 18 | Objection to the official caption pursuant to Rule 12 Practice Note by Appellee Actelion Pharmaceuticals, Ltd.. Service: 10/19/2016 by email. [375961] [Mark Waddell] [Entered: 10/19/2016 03:35 PM] (4) |
| Oct 19, 2016 | 17 | Docketing Statement for the Appellee Actelion Pharmaceuticals, Ltd.. Service: 10/19/2016 by email. [375958] [Mark Waddell] [Entered: 10/19/2016 03:33 PM] (4) |
| Oct 19, 2016 | 16 | Certificate of Interest for the Appellee Actelion Pharmaceuticals, Ltd.. Service: 10/19/2016 by email. [375957] [Mark Waddell] [Entered: 10/19/2016 03:33 PM] (2) |
| Oct 19, 2016 | 15 | Entry of appearance for Kathleen Gersh as of counsel for Appellee Actelion Pharmaceuticals, Ltd.. Service: 10/19/2016 by email. [375956] [Mark Waddell] [Entered: 10/19/2016 03:32 PM] (2) |
| Oct 19, 2016 | 14 | Entry of appearance for Warren K. MacRae as of counsel for Appellee Actelion Pharmaceuticals, Ltd.. Service: 10/19/2016 by email. [375954] [Mark Waddell] [Entered: 10/19/2016 03:31 PM] (2) |
| Oct 19, 2016 | 13 | Entry of appearance for Mark E. Waddell as principal counsel for Appellee Actelion Pharmaceuticals, Ltd.. Service: 10/19/2016 by email. [375951] [Mark Waddell] [Entered: 10/19/2016 03:29 PM] (2) |
| Oct 19, 2016 | 12 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [9], ERROR: Attorney Dan L. Wood submitted an entry of appearance without updating his CM/ECF account.. CORRECTION: Update your law firm and address through CM/ECF ASAP. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [375933] [FMS] [Entered: 10/19/2016 02:55 PM] (0) |
| Oct 19, 2016 | 11 | Docketing Statement for the Appellant ICOS Corporation. Service: 10/19/2016 by email. [375918] [Mark Feldstein] [Entered: 10/19/2016 02:23 PM] (3) |
| Oct 19, 2016 | 10 | Certificate of Interest for the Appellant ICOS Corporation. Service: 10/19/2016 by email. [375875] [Mark Feldstein] [Entered: 10/19/2016 01:38 PM] (3) |
| Oct 19, 2016 | 9 | Entry of appearance for Dan L. Wood as of counsel for Appellant ICOS Corporation. Service: 10/19/2016 by email. [375874] [Mark Feldstein] [Entered: 10/19/2016 01:37 PM] (2) |
| Oct 19, 2016 | 8 | Entry of appearance for Mark J. Stewart as of counsel for Appellant ICOS Corporation. Service: 10/19/2016 by email. [375873] [Mark Feldstein] [Entered: 10/19/2016 01:36 PM] (2) |
| Oct 19, 2016 | 7 | Entry of appearance for Yieyie Yang as of counsel for Appellant ICOS Corporation. Service: 10/19/2016 by email. [375871] [Mark Feldstein] [Entered: 10/19/2016 01:35 PM] (2) |
| Oct 19, 2016 | 6 | Entry of appearance for Jason L. Romrell as of counsel for Appellant ICOS Corporation. Service: 10/19/2016 by email. [375868] [Mark Feldstein] [Entered: 10/19/2016 01:34 PM] (2) |
| Oct 19, 2016 | 5 | Entry of appearance for Charles E. Lipsey as of counsel for Appellant ICOS Corporation. Service: 10/19/2016 by email. [375867] [Mark Feldstein] [Entered: 10/19/2016 01:33 PM] (2) |
| Oct 19, 2016 | 4 | Entry of appearance for Mark J. Feldstein as principal counsel for Appellant ICOS Corporation. Service: 10/19/2016 by email. [375864] [Mark Feldstein] [Entered: 10/19/2016 01:32 PM] (2) |
| Oct 19, 2016 | 3 | Note to file: The following cases are associated:17-1017 Lead with 17-1018 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [375660]--[Edited 10/25/2016 by clerk to correct the filed date of the event] [FMS] [Entered: 10/19/2016 09:11 AM] (0) |
| Oct 19, 2016 | 2 | ORDER consolidating appeals (17-1017 Lead with 17-1018 Consolidated ). Service as of this date by Clerk of Court. [375658] [17-1017, 17-1018]--[Edited 10/25/2016 by clerk to correct the filed date of the event] [FMS] [Entered: 10/19/2016 09:09 AM] (2) |
| Oct 5, 2016 | 1 | Appeal docketed. Received: 10/03/2016. [371926] Entry of Appearance due 10/19/2016. Certificate of Interest is due on 10/19/2016. Docketing Statement due 10/19/2016. Certified List due on 11/14/2016. [FMS] [Entered: 10/05/2016 03:09 PM] (48) |
